Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 22, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the SmithKline Beecham Employee Benefit Trust to participants in the GlaxoSmithKline Annual Investment Plan during August 2005:
- August 9, 2005: 4,746 shares transferred.
- August 10, 2005: 1,331 shares transferred.
- August 12, 2005: 3,486 shares transferred.
These transactions were notified to the company on August 15, 2005, and confirmed on August 19, 2005.
Management Commentary and Risks
The filing notes that the SmithKline Beecham Employee Benefit Trust is a discretionary fund for non-US employees and former employees. Director Mr. J. Heslop holds an interest in the shares held within this fund in the same capacity as other eligible employees. The notification complies with Disclosure Rule 3.1.4R(1)(b). No other risks, contingencies, or unusual items are discussed in this text.
Investor Verification Points
- Verify the total number of shares transferred from the Trust to the Annual Investment Plan (Total: 9,563 shares).
- Confirm the specific dates of transfer (August 9, 10, and 12, 2005).
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.